Literature DB >> 3366168

The disposition of biphenylacetic acid following topical application.

M Dawson1, C M McGee, J H Vine, P Nash, T R Watson, P M Brooks.   

Abstract

Plasma and synovial fluid concentrations of biphenylacetic acid were determined following application of 3 g of 3% biphenylacetic acid gel to one knee of patients suffering from rheumatoid arthritis. The mean peak plasma concentration was 34 ng/ml. Synovial fluid concentrations tended to follow plasma concentrations but at a somewhat lower level, the mean peak synovial fluid concentration was 21 ng/ml. The average ratio of synovial fluid AUC (0-24 h) to plasma AUC (0-24 h) was 0.58, r = 0.97. Where patients had bilateral effusions, the concentration in the ipsilateral knee at each time point examined was not significantly different to that in the contralateral knee, suggesting that absorption was initially into the plasma and subsequently into the synovium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366168     DOI: 10.1007/bf00542502

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  5 in total

1.  Quantitation of biphenylacetic acid in plasma and synovial fluid by gas chromatography-mass spectrometry-mass spectrometry.

Authors:  M Dawson; C M McGee; P M Brooks; J H Vine; E Lacey; T R Watson
Journal:  J Chromatogr       Date:  1987-09-04

2.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

3.  Synovial fluid kinetics of non-steroidal anti-inflammatory drugs.

Authors:  D E Furst
Journal:  Agents Actions Suppl       Date:  1985

4.  Basic and clinical studies of prodrugs of nonsteroidal anti-inflammatory drugs.

Authors:  Y Mizushima
Journal:  Pharmacology       Date:  1982       Impact factor: 2.547

5.  Pharmacokinetics of fenbufen in man.

Authors:  G Cuisinaud; J Legheand; G Llorca; C Belkahia; E Lejeune; J Sassard
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

  5 in total
  12 in total

1.  Estimation of intradermal disposition kinetics of drugs: I. Analysis by compartment model with contralateral tissues.

Authors:  K Nakayama; H Matsuura; M Asai; K Ogawara; K Higaki; T Kimura
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

Review 2.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

3.  Percutaneous absorption of topically applied NSAIDS and other compounds: role of solute properties, skin physiology and delivery systems.

Authors:  M S Roberts; S E Cross
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

Review 4.  Drug toxicity.

Authors:  H A Bird
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

5.  Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application.

Authors:  S E Cross; S A Megwa; H A Benson; M S Roberts
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

6.  Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application.

Authors:  P Singh; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

7.  A physiological pharmacokinetic model for solute disposition in tissues below a topical below a topical application site.

Authors:  M S Roberts; S E Cross
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

8.  Design and Evaluation of a Novel Felbinac Transdermal Patch: Combining Ion-Pair and Chemical Enhancer Strategy.

Authors:  Nannan Liu; Wenting Song; Tian Song; Liang Fang
Journal:  AAPS PharmSciTech       Date:  2015-06-13       Impact factor: 3.246

Review 9.  Topical NSAIDs for musculoskeletal conditions. A review of the literature.

Authors:  J H Vaile; P Davis
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

10.  Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies.

Authors:  S E Cross; C Anderson; M S Roberts
Journal:  Br J Clin Pharmacol       Date:  1998-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.